As of Jun 18
| -0.035 / -3.35%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +48.51% increase from the last price of 1.01.
The current consensus among 1 polled investment analysts is to Hold stock in Titan Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.